Open AccessEfficacy and Safety of an Octreotide Implant in the Treatment of Patients With Acromegaly
Author(s) -
Carla Chieffo,
David M. Cook,
Qinfang Xiang,
Lawrence A. Frohman
Publication year - 2013
Publication title -
the journal of clinical endocrinology and metabolism
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.206
H-Index - 353
eISSN - 1945-7197
pISSN - 0021-972X
DOI - 10.1210/jc.2013-2262
Subject(s) - acromegaly , octreotide , medicine , growth hormone , somatostatin , hormone
Acromegaly is caused by excessive GH secretion and IGF-I overproduction. The goals of treatment are to reduce GH and IGF-I values to normal and relieve the associated symptoms.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom